INTERNATIONAL JOURNAL OF CARDIOLOGY, vol.223, pp.543-547, 2016 (SCI-Expanded)
Objective: To compare the distribution of international normalized ratios (INRs) in patients receiving vitamin K antagonist (VKA) for newly diagnosed atrial fibrillation in Eastern and Southeastern Asia and in other regions of the world (ORW) represented in the ongoing, global observational study GARFIELD-AF.